Day ML - Search Results

1

The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer.

Kuefer R, Hofer MD, Gschwend JE, Pienta KJ, Sanda MG, Chinnaiyan AM, Rubin MA, Day ML. Kuefer R, et al. Among authors: day ml. Clin Cancer Res. 2003 Dec 15;9(17):6447-52. Clin Cancer Res. 2003. PMID: 14695147

2

Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.

Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R. Raffo AJ, et al. Among authors: day ml. Cancer Res. 1995 Oct 1;55(19):4438-45. Cancer Res. 1995. PMID: 7671257

3

Retinoblastoma protein-dependent growth signal conflict and caspase activity are required for protein kinase C-signaled apoptosis of prostate epithelial cells.

Zhao X, Gschwend JE, Powell CT, Foster RG, Day KC, Day ML. Zhao X, et al. Among authors: day ml, day kc. J Biol Chem. 1997 Sep 5;272(36):22751-7. doi: 10.1074/jbc.272.36.22751. J Biol Chem. 1997. PMID: 9278434 Free article.

4

Paclitaxel-associated multimininucleation is permitted by the inhibition of caspase activation: a potential early step in drug resistance.

Panvichian R, Orth K, Day ML, Day KC, Pilat MJ, Pienta KJ. Panvichian R, et al. Among authors: day ml, day kc. Cancer Res. 1998 Oct 15;58(20):4667-72. Cancer Res. 1998. PMID: 9788620

5

Signaling network of paclitaxel-induced apoptosis in the LNCaP prostate cancer cell line.

Panvichian R, Orth K, Pilat MJ, Day ML, Day KC, Yee C, Kamradt JM, Pienta KJ. Panvichian R, et al. Among authors: day ml, day kc. Urology. 1999 Oct;54(4):746-52. doi: 10.1016/s0090-4295(99)00224-1. Urology. 1999. PMID: 10510942

6

Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution.

Vallorosi CJ, Day KC, Zhao X, Rashid MG, Rubin MA, Johnson KR, Wheelock MJ, Day ML. Vallorosi CJ, et al. Among authors: day ml, day kc. J Biol Chem. 2000 Feb 4;275(5):3328-34. doi: 10.1074/jbc.275.5.3328. J Biol Chem. 2000. PMID: 10652321 Free article.

7

Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate.

Rashid MG, Sanda MG, Vallorosi CJ, Rios-Doria J, Rubin MA, Day ML. Rashid MG, et al. Among authors: day ml. Cancer Res. 2001 Jan 15;61(2):489-92. Cancer Res. 2001. PMID: 11212238

8

Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors.

Chaib H, Rubin MA, Mucci NR, Li L, Taylor JMG, Day ML, Rhim JS, Macoska JA. Chaib H, et al. Among authors: day ml. Cancer Res. 2001 Mar 15;61(6):2390-4. Cancer Res. 2001. PMID: 11289102

9

E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.

Rubin MA, Mucci NR, Figurski J, Fecko A, Pienta KJ, Day ML. Rubin MA, et al. Among authors: day ml. Hum Pathol. 2001 Jul;32(7):690-7. doi: 10.1053/hupa.2001.25902. Hum Pathol. 2001. PMID: 11486167

10

The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells.

Rios-Doria J, Day KC, Kuefer R, Rashid MG, Chinnaiyan AM, Rubin MA, Day ML. Rios-Doria J, et al. Among authors: day ml, day kc. J Biol Chem. 2003 Jan 10;278(2):1372-9. doi: 10.1074/jbc.M208772200. Epub 2002 Oct 19. J Biol Chem. 2003. PMID: 12393869 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters